DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cyclophosphamide (Cyclophosphamide) - Serious Reactions - Suspected Cause - Side Effect Reports

 
 



Index of reports > Serious Reactions (2508)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cyclophosphamide serious reactions. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 2508   Next >>

Possible Cyclophosphamide side effects in 49 year old male

Reported by a physician from Norway on 2012-08-27

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: on day 8
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for escalated cycles on day 1
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for standard cycles on day 1

Doxorubicin Hydrochloride
    Dosage: for escalated cycles on day 1
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Dosage: on day 1,for standard cycles

Etoposide
    Dosage: for the escalated cycles on day 1 to 3

Etoposide
    Dosage: for the escalated cycles on day 1 to 3

Etoposide
    Dosage: for the standard cycles, day 1 to 3
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: day 1 to 7
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine
    Dosage: on day 8
    Indication: Hodgkin's Disease



Possible Cyclophosphamide side effects in 62 year old female

Reported by a physician from Spain on 2012-08-27

Patient: 62 year old female

Reactions: Osteonecrosis

Drug(s) suspected as cause:
Anastrozole
    Dosage: 1 mg/day
    Indication: Breast Cancer

Cyclophosphamide
    Dosage: 600 mg/m2 q21d (4 cycles)
    Indication: Breast Cancer

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2 q21d (4 cycles)
    Indication: Breast Cancer

Other drugs received by patient: Dexamethasone; Chlorhexidine Gluconate; Omeprazole



Possible Cyclophosphamide side effects in male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-27

Patient: male

Reactions: Dystonia, Encephalopathy, Parkinsonism

Drug(s) suspected as cause:
Cisplatin

Cyclophosphamide

Etoposide

Ifosfamide

Vincristine



Possible Cyclophosphamide side effects in

Reported by a physician from Germany on 2012-08-27

Patient:

Reactions: Acute Myeloid Leukaemia

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Chronic Lymphocytic Leukaemia

Fludarabine Phosphate
    Indication: Chronic Lymphocytic Leukaemia

Ofatumumab
    Indication: Chronic Lymphocytic Leukaemia



Possible Cyclophosphamide side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: Off Label Use, Gastrointestinal Toxicity, Neutropenia, Infection

Drug(s) suspected as cause:
Carboplatin
    Dosage: 6 courses in high risk
    Indication: Retinoblastoma

Cyclophosphamide
    Indication: Retinoblastoma

Doxorubicin Hydrochloride
    Dosage: 4 courses in intermediate risk and 6 courses in high risk
    Indication: Retinoblastoma

Etoposide
    Indication: Retinoblastoma

Vincristine
    Dosage: 4 courses in intermediate risk and 6 courses in high risk
    Indication: Retinoblastoma

Other drugs received by patient: Neupogen



Possible Cyclophosphamide side effects in 47 year old male

Reported by a physician from France on 2012-08-27

Patient: 47 year old male

Reactions: Respiratory Tract Infection Bacterial, Epstein-Barr Virus Associated Lymphoma, Congestive Cardiomyopathy, Systolic Dysfunction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Start date: 2012-06-08

Doxorubicin HCL
    Start date: 2012-06-11
    End date: 2012-07-10

Mabthera
    Start date: 2012-06-11

Nexium
    Administration route: Oral

Prednisolone
    Administration route: Oral
    Start date: 2012-06-08

Vincristine
    Start date: 2012-06-08

Other drugs received by patient: Previscan; Methotrexate Sodium; Potassium Chloride; Kineret; Kineret; Kineret; Cacit D3; Aspirin; Prednisone TAB; Acetaminophen; Acetaminophen W / Codeine; Alendronate Sodium / Cholecalciferol



Possible Cyclophosphamide side effects in 57 year old female

Reported by a physician from Croatia (Local Name: Hrvatska) on 2012-08-27

Patient: 57 year old female

Reactions: Breast Cancer Metastatic, Paraneoplastic Dermatomyositis, Pulmonary Embolism

Adverse event resulted in: death

Drug(s) suspected as cause:
Capecitabine
    Administration route: Oral
    Indication: Breast Cancer

Cisplatin
    Dosage: 6 cycles
    Indication: Breast Cancer

Cyclophosphamide
    Dosage: 6 cycles
    Indication: Breast Cancer

Doxorubicin Hydrochloride
    Dosage: 6 cycles
    Indication: Breast Cancer

Gemcitabine Hydrochloride
    Indication: Breast Cancer

Paclitaxel
    Indication: Breast Cancer



Possible Cyclophosphamide side effects in 49 year old male

Reported by a physician from Norway on 2012-08-27

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: 10000 iu, day 8 (2 escalated cycles)
    Indication: Hodgkin's Disease

Bleomycin Sulfate
    Dosage: 10000 iu, day 8 (4 standard cycles)

Cyclophosphamide
    Dosage: 650 mg/m2, day 1 (4 standard cycles)

Cyclophosphamide
    Dosage: 1250 mg/m2, day 1 (2 escalated cycles)
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 25 mg/m2, day 1 (4 standard cycles)

Doxorubicin HCL
    Dosage: 35 mg/m2, day 1 (2 escalated cycles)
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 100 mg/m2, day 1-3 (4 standard cycles)

Etoposide
    Dosage: 200 mg/m2, day 1-3 (2 escalated cycles)
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: 40 mg/m2, day 1-14 (4 standard cycles)
    Administration route: Oral

Prednisolone
    Dosage: 40 mg/m2, day 1-14 (2 escalated cycles)
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: 100 mg/m2, day 1-7 (2 escalated cycles)
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: 100 mg/m2, day 1-7 (4 standard cycles)
    Administration route: Oral

Vincristine
    Dosage: 1.4 mg/m2, day 8 (2 escalated cycles)
    Indication: Hodgkin's Disease

Vincristine
    Dosage: 1.4 mg/m2, day 8 (4 standard cycles)



Possible Cyclophosphamide side effects in female

Reported by a physician from Bulgaria on 2012-08-24

Patient: female, weighing 63.0 kg (138.6 pounds)

Reactions: Circulatory Collapse, Bone Marrow Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1000 milligram
    Indication: Multiple Myeloma
    Start date: 2012-05-23
    End date: 2012-05-25

Dexamethasone
    Dosage: 40 milligram
    Start date: 2012-06-02
    End date: 2012-06-05

Dexamethasone
    Dosage: 40 milligram
    Indication: Multiple Myeloma
    Start date: 2012-05-23
    End date: 2012-05-26

Dexamethasone
    Dosage: 20 milligram
    Start date: 2012-05-16
    End date: 2012-05-19

Doxorubicin Hydrochloride
    Dosage: 80 milligram
    Indication: Multiple Myeloma
    Start date: 2012-05-26
    End date: 2012-05-26

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-30
    End date: 2012-06-07

Vincristine
    Dosage: 2 milligram
    Indication: Multiple Myeloma
    Start date: 2012-05-26
    End date: 2012-06-02

Other drugs received by patient: Milgamma; Dopamine HCL; Nexium; Atropine; Sodium Carbonate; Lyrica; Uromithexane; Electrolyte Infusions; Sodium Bicarbonate; Probitor; Tevagrastim



Possible Cyclophosphamide side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: male, weighing 103.1 kg (226.8 pounds)

Reactions: Plasmacytosis, Pneumonia, Mouth Haemorrhage, Pseudomonas Infection, Headache, Disease Progression, Death, Mucosal Inflammation, Pleural Effusion, Depressed Level of Consciousness, Abscess, Lethargy, RIB Fracture

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Indication: Multiple Myeloma

Cyclophosphamide
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Indication: Multiple Myeloma

Etoposide
    Indication: Multiple Myeloma

Radiation Therapy NOS
    Indication: Multiple Myeloma

Revlimid
    Indication: Multiple Myeloma

Thalidomide
    Indication: Multiple Myeloma

Velcade
    Indication: Multiple Myeloma

Other drugs received by patient: Bendamustine Hydrochloride; Lenalidomide



Possible Cyclophosphamide side effects in 52 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: 52 year old female

Reactions: Tumour Lysis Syndrome, Posterior Reversible Encephalopathy Syndrome, Insomnia, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: according to larson regimen
    Indication: B Precursor Type Acute Leukaemia

Daunorubicin HCL
    Dosage: according to larson regimen
    Indication: B Precursor Type Acute Leukaemia

Daunorubicin HCL
    Dosage: at 50% dosage

Dexamethasone
    Indication: Premedication

Methylprednisolone Sodium Succinate
    Indication: B Precursor Type Acute Leukaemia

Prednisone TAB
    Dosage: according to larson regimen
    Indication: B Precursor Type Acute Leukaemia

Vincristine
    Dosage: according to larson regimen
    Indication: B Precursor Type Acute Leukaemia

Other drugs received by patient: Ondansetron; Voriconazole; Morphine Sulfate; Morphine



Possible Cyclophosphamide side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: male, weighing 121.9 kg (268.2 pounds)

Reactions: Pruritus, Unresponsive To Stimuli, Device Related Infection, Pyrexia, Candidiasis, Abscess Limb, Ventricular Extrasystoles, Metabolic Acidosis, Dyspnoea, Hypotension, Pancytopenia, Tremor, Convulsion, Respiratory Failure, Fungal Infection, Ventricular Tachycardia, Sepsis, Respiratory Arrest, Pulse Absent, Sinus Tachycardia, Hypertension, Feeling Abnormal, Cardiac Arrest, Escherichia Infection, Infusion Related Reaction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clolar
    Dosage: 74.4 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-19
    End date: 2012-06-23

Cyclophosphamide
    Dosage: daily for 5 days
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-19
    End date: 2012-06-23

Epinephrine
    Dosage: 4 df, unk
    Indication: Cardiac Arrest
    Start date: 2012-07-14
    End date: 2012-07-14

Epinephrine
    Dosage: unk
    Start date: 2012-07-14
    End date: 2012-07-14

Etoposide
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-19
    End date: 2012-06-23

Oncaspar
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-07-02
    End date: 2012-07-02

Vincristine Sulfate
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-07-02
    End date: 2012-07-02

Other drugs received by patient: Colace; Bactrim; Stomatitis Mouthwash; Prilosec; Lortab; Cymbalta; Ondansetron; Ambien



Possible Cyclophosphamide side effects in 49 year old male

Reported by a physician from Norway on 2012-08-24

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: on day 8
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for escalated cycles on day 1
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for standard cycles on day 1

Doxorubicin Hydrochloride
    Dosage: on day 1,for standard cycles

Doxorubicin Hydrochloride
    Dosage: for escalated cycles on day 1
    Indication: Hodgkin's Disease

Etoposide
    Dosage: for the escalated cycles on day 1 to 3

Etoposide
    Dosage: for the escalated cycles on day 1 to 3

Etoposide
    Dosage: for the standard cycles, day 1 to 3
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: day 1 to 7
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine
    Dosage: on day 8
    Indication: Hodgkin's Disease



Possible Cyclophosphamide side effects in 51 year old male

Reported by a physician from Germany on 2012-08-24

Patient: 51 year old male

Reactions: Progressive Multifocal Leukoencephalopathy

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Indication: HIV Infection

Doxorubicin HCL
    Indication: HIV Infection

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma

Mabthera
    Indication: non-Hodgkin's Lymphoma

Mabthera
    Indication: HIV Infection

Prednisone
    Indication: HIV Infection

Prednisone TAB
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Indication: HIV Infection

Vincristine
    Indication: non-Hodgkin's Lymphoma



Possible Cyclophosphamide side effects in male

Reported by a consumer/non-health professional from France on 2012-08-23

Patient: male, weighing 79.0 kg (173.8 pounds)

Reactions: Abdominal Pain Lower, Bronchopulmonary Aspergillosis, Prostatitis, Cystitis Haemorrhagic, Human Polyomavirus Infection, Pyrexia, Dysuria, Adenovirus Infection, Pollakiuria

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg/m2, 3 times per 1 cycle
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Cyclophosphamide
    Dosage: 500 mg/m2, unk
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Fludara
    Dosage: 80 mg/m2, unk
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Other drugs received by patient: Valganciclovir; Bactrim; Folic Acid; Vfend



Possible Cyclophosphamide side effects in male

Reported by a physician from United States on 2012-08-23

Patient: male

Reactions: Death, Chalazion

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Lenalidomide
    Indication: Multiple Myeloma

Velcade
    Dosage: 2 mg, 1/week
    Indication: Multiple Myeloma
    Start date: 2009-08-13
    End date: 2012-01-03

Other drugs received by patient: Bisphosphonates; Travoprost



Possible Cyclophosphamide side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient: male

Reactions: Phlebitis, Lymphocyte Percentage Decreased, Hydronephrosis, Arterial Thrombosis Limb, Urinary Tract Infection, Cystitis Noninfective, Human Polyomavirus Infection, Prothrombin Time Prolonged, Urethritis, Blood Fibrinogen Increased, Genitourinary Tract Infection, Renal Impairment, Adenovirus Infection, Prostatomegaly, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg/m2, first 3 days of each cycle (6 cycles)
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Cyclophosphamide
    Dosage: 500 mg/m2, first 3 days of each cycle (6 cycles)
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Fludara
    Dosage: 80 mg/m2, first 3 days of each cycle (6 cycles)
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Other drugs received by patient: Bactrim; Valganciclovir; Vfend; Folic Acid



Possible Cyclophosphamide side effects in male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-23

Patient: male

Reactions: Dystonia, Encephalopathy, Parkinsonism

Drug(s) suspected as cause:
Cisplatin

Cyclophosphamide

Etoposide

Ifosfamide

Vincristine



Possible Cyclophosphamide side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient: male, weighing 79.0 kg (173.8 pounds)

Reactions: Phlebitis, Hydronephrosis, Adenovirus Infection, Cystitis Haemorrhagic, Human Polyomavirus Infection, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg/m2, on first 3 days of each cycle (total 6 cycles)
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Cyclophosphamide
    Dosage: 500 mg/m2, on first 3 days of each cycle (total 6 cycles)
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Fludara
    Dosage: 80 mg/m2, on first 3 days of each cycle (total 6 cycles)
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Other drugs received by patient: Folic Acid; Bactrim; Vfend; Valganciclovir



Possible Cyclophosphamide side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Stomatitis, Anaemia, Febrile Neutropenia, Constipation, Neutrophil Count Decreased

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 700 mg, qd
    Start date: 2010-10-26
    End date: 2010-10-26

Cyclophosphamide
    Dosage: 700 mg, qd
    Start date: 2010-12-07
    End date: 2010-12-07

Cyclophosphamide
    Dosage: 700 mg, qd
    Start date: 2010-11-16
    End date: 2010-11-16

Cyclophosphamide
    Dosage: 700 mg, once
    Indication: Breast Cancer
    Start date: 2010-09-29
    End date: 2010-10-29

Emend
    Dosage: 80 mg, qd
    Administration route: Oral
    Start date: 2010-10-27
    End date: 2010-10-28

Emend
    Dosage: 125 mg, qd
    Administration route: Oral
    Start date: 2010-12-07
    End date: 2010-12-07

Emend
    Dosage: 125 mg, once
    Administration route: Oral
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2010-09-29
    End date: 2010-09-29

Emend
    Dosage: 125 mg, qd
    Administration route: Oral
    Start date: 2010-10-26
    End date: 2010-10-26

Emend
    Dosage: 80 mg, qd
    Administration route: Oral
    Start date: 2010-09-30
    End date: 2010-10-01

Emend
    Dosage: 80 mg, qd
    Administration route: Oral
    Start date: 2010-12-08
    End date: 2010-12-09

Emend
    Dosage: 80 mg, qd
    Administration route: Oral
    Start date: 2010-11-17
    End date: 2010-11-18

Emend
    Dosage: 125 mg, qd
    Administration route: Oral
    Start date: 2010-11-16
    End date: 2010-11-16

Epirubicin Hydrochloride
    Dosage: |100 mg, once
    Indication: Breast Cancer
    Start date: 2010-09-29
    End date: 2010-09-29

Epirubicin Hydrochloride
    Dosage: 100 mg, qd
    Start date: 2010-12-07
    End date: 2010-12-07

Epirubicin Hydrochloride
    Dosage: 100 mg, qd
    Start date: 2010-10-26
    End date: 2010-10-26

Epirubicin Hydrochloride
    Dosage: 100 mg, qd
    Start date: 2010-11-16
    End date: 2010-11-16

Other drugs received by patient: Granisetron Hydrochloride; Dexamethasone Sodium Phosphate; Mucosta; Decadron Phosphate; Dexamethasone Sodium Phosphate; Mucosta; Decadron Phosphate; Granisetron Hydrochloride; Mucosta; Mucosta; Granisetron Hydrochloride; Decadron Phosphate; Dexamethasone Sodium Phosphate; Granisetron Hydrochloride; Decadron Phosphate; Dexamethasone Sodium Phosphate



Possible Cyclophosphamide side effects in female

Reported by a health professional (non-physician/pharmacist) from China on 2012-08-23

Patient: female, weighing 50.0 kg (110.0 pounds)

Reactions: Hepatic Function Abnormal

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: B-Cell Lymphoma
    Start date: 2010-08-25

Mabthera
    Indication: B-Cell Lymphoma
    Start date: 2010-08-25

Pirarubicin
    Indication: B-Cell Lymphoma
    Start date: 2010-08-25



Possible Cyclophosphamide side effects in female

Reported by a physician from United States on 2012-08-23

Patient: female

Reactions: Chalazion

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Lenalidomide
    Indication: Multiple Myeloma

Velcade
    Dosage: 2 mg, 1/week
    Indication: Multiple Myeloma
    Start date: 2008-11-13

Other drugs received by patient: Synthroid; Bisphosphonates



Possible Cyclophosphamide side effects in male

Reported by a physician from United States on 2012-08-23

Patient: male

Reactions: Chalazion

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Lenalidomide
    Indication: Multiple Myeloma

Velcade
    Dosage: 2 mg, 1/week
    Indication: Multiple Myeloma
    Start date: 2010-09-13

Other drugs received by patient: Bisphosphonates; Doxazosin Mesylate



Possible Cyclophosphamide side effects in female

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-08-23

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Graft Versus Host Disease, Staphylococcal Infection, Chills, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Cyclophosphamide
    Dosage: 4380 mg, unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-11

Other drugs received by patient: Sulfamethoxazole Trimethoprim



Possible Cyclophosphamide side effects in 49 year old male

Reported by a physician from Norway on 2012-08-23

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Septic Shock, Lung Infiltration

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Baxter 15 000 IE Lyofilisat TIL Injeksjonsv?ske / Infusjonsv?s

Cyclophosphamide

Cyclophosphamide

Doxorubicin Hydrochloride

Doxorubicin Hydrochloride

Etoposide

Etoposide

Prednisolone
    Administration route: Oral

Procarbazine Hydrochloride
    Administration route: Oral

Vincristine



Possible Cyclophosphamide side effects in 64 year old male

Reported by a physician from Germany on 2012-08-23

Patient: 64 year old male, weighing 87.0 kg (191.4 pounds)

Reactions: Malignant Melanoma in Situ

Drug(s) suspected as cause:
Cyclophosphamide
    Start date: 2011-08-17
    End date: 2011-08-18

Dexamethasone
    Dosage: 40 milligram
    Indication: Multiple Myeloma
    Start date: 2011-05-10
    End date: 2011-08-02

Etoposide
    Start date: 2011-08-17
    End date: 2011-08-19

Lenograstim
    Indication: Multiple Myeloma
    Start date: 2011-08-21
    End date: 2011-08-30

Melphalan Hydrochloride
    Indication: Multiple Myeloma
    Start date: 2011-09-20

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-05-10
    End date: 2011-08-01

Other drugs received by patient: Diltiazem; Omeprazole; Albuterol Sulate; Cotrim DS; Micardis; Loratadine; Diazepam; Aspirin; Acyclovir



Possible Cyclophosphamide side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Chalazion

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Lenalidomide
    Indication: Multiple Myeloma

Velcade
    Dosage: 2 mg, 1/week
    Indication: Multiple Myeloma
    Start date: 2009-04-01
    End date: 2011-02-10

Other drugs received by patient: Zocor; Aredia; Actonel; Bisphosphonates; Lasix; Multi Vitamin and Mineral + Selenium; Comadin



Possible Cyclophosphamide side effects in 56 year old female

Reported by a physician from United Kingdom on 2012-08-23

Patient: 56 year old female, weighing 86.4 kg (190.1 pounds)

Reactions: Gastrooesophageal Reflux Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Start date: 2012-06-15

Dexamethasone
    Start date: 2012-06-15
    End date: 2012-06-15

Docetaxel
    Start date: 2012-06-15

Epirubicin Hydrochloride
    Start date: 2012-06-15

Fluorouracil
    Start date: 2012-06-15

Ondansetron
    Start date: 2012-06-15
    End date: 2012-06-15

Other drugs received by patient: Acetaminophen; Filgrastim; Ibuprofen



Possible Cyclophosphamide side effects in 60 year old female

Reported by a physician from United Kingdom on 2012-08-23

Patient: 60 year old female

Reactions: Night Sweats, Endophthalmitis, Fungal Endocarditis, Pancytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath-1
    Indication: Chronic Lymphocytic Leukaemia

Cyclophosphamide
    Indication: Chronic Lymphocytic Leukaemia

Fludara
    Indication: Chronic Lymphocytic Leukaemia

Mycophenolate Mefetil
    Indication: Graft Versus Host Disease



Possible Cyclophosphamide side effects in 9 year old female

Reported by a individual with unspecified qualification from China on 2012-08-22

Patient: 9 year old female

Reactions: Hypertensive Encephalopathy

Drug(s) suspected as cause:
Cyclophosphamide

Other drugs received by patient: Methylprednisolone; Prednisone TAB



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014